Skip to Main Content

Paper Details

Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer.
Eur Urol Oncol
38
2019
68Ga, BAY86-7548, GRPR, PARTICIPANTS, PATIENT, PCa, PSMA, Prostate Cancer, cancer, men, prostate cancer, prostate-specific membrane antigen, tumor
Author NameAffiliation
Anuradha GopalanMemorial Sloan Kettering Cancer Center
Mithat GonenMemorial Sloan Kettering Cancer Center
  • 1 - 2

Datasets

Release 1.2